CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 133 filers reported holding CTI BIOPHARMA CORP in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,365,246 | -13.0% | 1,753,630 | +24.5% | 1.60% | -28.9% |
| Q4 2022 | $8,465,938 | +20.2% | 1,408,642 | +16.4% | 2.25% | +12.6% |
| Q3 2022 | $7,043,000 | +12.2% | 1,210,145 | +15.1% | 2.00% | -13.4% |
| Q2 2022 | $6,275,000 | +497.1% | 1,051,047 | +367.1% | 2.31% | +650.3% |
| Q1 2022 | $1,051,000 | – | 225,000 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Legal & General Group Plc | 9,340 | $84,901 | 0.00% |
| UBS ASSET MANAGEMENT AMERICAS INC | 92,700 | $389,340 | 0.00% |
| FNY Investment Advisers, LLC | 20 | $0 | 0.00% |